Nexstim
Warrants to be topped up with share placementNexstim
Q319 update shows therapy business momentumNexstim
A possible new opportunity in severe depressionNexstim
Voluntary loan repayments remove Kreos uncertaintyNexstim
Promising progress with NBTNexstim
Getting back on the front footNexstim
Terms of the rights issue announcedNexstim
Securing the commercial future of NBT in depressionNexstim
Achieving commendable outcomes in depressionNexstim
Navigating the opportunity in depression